(Q46436945)

English

Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

1 reference

based on heuristic

inferred from title

author name string

Louis Mini

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Sherry Wang-Weigand

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Jeff Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

30

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

1316-1323

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Insomnia: epidemiology, characteristics, and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Benzodiazepine Withdrawal Symptom Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of indiplon in older adults with primary insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability, validity, and clinical application of the Visual Analogue Mood Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo effects in primary insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2808%2980056-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(08)80056-2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18691991

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46436945&oldid=2111690238"